Company Filing History:
Years Active: 2013
Title: **Mordechai Farbstein: Innovator in Ocular Pressure Treatments**
Introduction
Mordechai Farbstein is an inventive force hailing from Ganei Tikva, Israel. With a focus on the medical field, he has made a significant contribution through his innovative research aimed at improving the treatment of intraocular pressure.
Latest Patents
Farbstein holds a patent for "A3 Adenosine Receptor Agonists for the Reduction of Intraocular Pressure." This patent outlines the use of an A3R agonist, particularly IB-MECA, which demonstrates efficacy in reducing intraocular pressure (IOP) in human subjects. The invention not only provides a novel pharmaceutical composition but also details methods for effectively utilizing the A3R agonist to manage IOP.
Career Highlights
Mordechai Farbstein is currently affiliated with Can-Fite Biopharma Ltd., a company known for its commitment to advancing biotechnology solutions. His work with Can-Fite showcases his dedication to developing innovative therapies that address significant medical challenges, particularly in the area of ophthalmology.
Collaborations
Farbstein has had the opportunity to collaborate with notable individuals in the field, including his colleague Pnina Fishman. Together, they contribute to the advancement of research and development in innovative medical treatments.
Conclusion
Mordechai Farbstein's contributions to the field of medical innovation demonstrate the vital role of inventors in addressing healthcare needs. His patented work not only represents a significant scientific breakthrough but also exemplifies the ongoing quest for effective treatments in ophthalmology, impacting patients' lives positively.